In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 354 for your search:
Drug:  bortezomib
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C05004, NCT00257114

2.

Phase: Phase IV
Type: Natural history/Epidemiology, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR003469, 26866138MMY4001, NCT00440765

3.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: TaCyDexVMP7, NCT00652041

4.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR012958, bortezomib PMS, NCT01005628

5.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR015814, 26866138MMY4039, BORKOR5021, NCT01030302

6.

Phase: Phase IV
Type: Natural history/Epidemiology
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR016750, BOR-KOR-5022, NCT01060202

7.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CLBH589DUS71, NCT01083602

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA200-003, KAG-302, NCT00514371

9.

Phase: Phase III, Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: R08096M, 2008-003936-38, 26866138MMY2063, NCT00861250

10.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MILLENNIUM-M34101-040, FHCRC-1747.00, NCI-G02-2128, NCT00049478

11.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MILLENNIUM-M34101-039, FHCRC-1746.00, NCI-G02-2130, NCT00048230

12.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UARK 2003-35, NCT00093028

13.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR004117, DOXILMMY3001, 2004-001842-34, NCT00103506

14.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: UARK 2005-01, NCT00111748

15.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT: 2005-001628-35, EBMT-CLWP: 42206611, NCT00256776

16.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: BRD 04/11-J, NCT00200681

17.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 26866138-MMY-3002, UCLA-0409110-01, JJPRD-26866138-MMY-3002, NCT00111319

18.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 61 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR006127, 26866138MMY3013, NCT00416208

19.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 0 to 60
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR006124, 26866138MMY3012, 2005-004948-31, NCT00416273

20.

Phase: Phase III
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: 26866138-LYM-3001, NCT00312845

21.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: NMSG 15/05, EudraCT No: 2005-002756-18, NCT00417911

22.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 66 and over
Sponsor: Other
Protocol IDs: 2005-001111-21, NCT00443235

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 65 and under
Sponsor: Other
Protocol IDs: 2005-001110-41, NCT00461747

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: C05009, NCT00507416

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00521, CDR0000561758, ECOG-E1A05, E1A05, U10CA021115, U10CA180820, NCT00522392
1     
New Search